Epidermal Growth Factor‐Like Repeats and Discoidin I‐Like Domains 3 Deficiency Attenuates Dilated Cardiomyopathy by Inhibiting Ubiquitin Specific Peptidase 10 Dependent Smad4 Deubiquitination
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.123.031283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Mengmeng Zhao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, Department of Geriatrics Zhongnan Hospital of Wuhan University, Wuhan University Wuhan…. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Dilated cardiomyopathy (DCM) is the leading cause of heart failure with a poor prognosis. Recent studies suggest that endothelial to mesenchymal transition (EndMT) may be involved in the pathogenesis and cardiac remodeling during DCM development. EDIL3 (epidermal growth factor‐like repeats and discoidin I‐like domains 3) is an extracellular matrix glycoprotein that has been reported to promote EndMT in various diseases. However, the roles of EDIL3 in DCM still remain unclear. Methods and Results A mouse model of DCM and human umbilical vein endothelial cells were used to explore the roles and mechanisms of EDIL3 in DCM. The results indicated that EndMT and EDIL3 were activated in DCM mice. EDIL3 deficiency attenuated cardiac dysfunction and remodeling in DCM mice. EDIL3 knockdown alleviated EndMT by inhibiting USP10 (ubiquitin specific peptidase 10) dependent Smad4 deubiquitination in vivo and in vitro. Recombinant human EDIL3 promoted EndMT via reinforcing deubiquitination of Smad4 in human umbilical vein endothelial cells treated with IL‐1β (interleukin 1β) and TGF‐β (transforming growth factor beta). Inhibiting USP10 abolished EndMT exacerbated by EDIL3. In addition, recombinant EDIL3 also aggravates doxorubicin‐induced EndMT by promoting Smad4 deubiquitination in HUVECs.
Conclusions
Taken together, these results indicate that EDIL3 deficiency attenuated EndMT by inhibiting USP10 dependent Smad4 deubiquitination in DCM mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Renmin Hospital of Wuhan University, Department of Geriatrics Zhongnan Hospital of Wuhan University, Wuhan University Wuhan China.
- Cardiovascular Research Institute Wuhan University Wuhan China.
- Hubei Key Laboratory of Cardiology Wuhan China.
- Center for Healthy Aging Wuhan University School of Nursing Wuhan China.
ORCID-Profile: Mengmeng Zhao, Shanshan Peng, Jishou Zhang, Wei Pan, Cheng Wei, Menglong Wang, Jun Wan, Juan-Juan Qin
Zitieren
APA
Zhao, M., Zheng, Z., Peng, S., Xu, Y., Zhang, J., Liu, J., Pan, W., Yin, Z., Xu, S., Wei, C., Wang, M., Wan, J., & Qin, J. J. (2024). Epidermal Growth Factor‐Like Repeats and Discoidin I‐Like Domains 3 Deficiency Attenuates Dilated Cardiomyopathy by Inhibiting Ubiquitin Specific Peptidase 10 Dependent Smad4 Deubiquitination. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.031283
Vancouver
Zhao M, Zheng Z, Peng S, Xu Y, Zhang J, Liu J, et al. Epidermal Growth Factor‐Like Repeats and Discoidin I‐Like Domains 3 Deficiency Attenuates Dilated Cardiomyopathy by Inhibiting Ubiquitin Specific Peptidase 10 Dependent Smad4 Deubiquitination. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.031283
BibTeX
@article{Zhao2024,
author = {Zhao, Mengmeng and Zheng, Zihui and Peng, Shanshan and Xu, Yao and Zhang, Jishou and Liu, Jianfang and Pan, Wei and Yin, Zheng and Xu, Shuwan and Wei, Cheng and Wang, Menglong and Wan, Jun and Qin, Juan-Juan},
title = {Epidermal Growth Factor‐Like Repeats and Discoidin I‐Like Domains 3 Deficiency Attenuates Dilated Cardiomyopathy by Inhibiting Ubiquitin Specific Peptidase 10 Dependent Smad4 Deubiquitination},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.123.031283}
}
EUVIMED